Ondine Biomedical Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	5.57	9.77	2.98	13.13	30.37	0.63
Cash & Short-Term Investments	5.57	9.77	2.98	13.13	30.37	0.63
Cash Growth	357.14%	227.64%	-77.29%	-56.78%	4750.64%	-28.58%
Accounts Receivable	0.32	0.46	0.32	0.13	0.16	0.54
Other Receivables	0.02	0.06	0	0.05	0.09	0.01
Receivables	0.34	0.51	0.33	0.18	0.25	0.54
Inventory	1.33	1.27	1.07	1.29	1.06	0.4
Prepaid Expenses	0.28	0.48	0.22	0.38	1.83	0.17
Restricted Cash	-	0.16	0.16	0.15	-	-
Total Current Assets	7.51	12.19	4.75	15.13	33.5	1.75
Property, Plant & Equipment	1.21	0.6	0.95	1.4	0.6	0.67
Other Intangible Assets	-	-	-	-	-	0.17
Other Long-Term Assets	0.04	0.04	0.04	0.04	0.04	0.05
Total Assets	8.76	12.82	5.73	16.57	34.14	2.64
Accounts Payable	1.39	1.59	1.36	0.39	1.2	0.77
Accrued Expenses	6.04	4.19	1.75	3.16	2.08	0.64
Short-Term Debt	-	-	-	-	-	26.99
Current Portion of Long-Term Debt	-	-	-	-	-	7.16
Current Portion of Leases	0.31	0.17	0.38	0.36	0.15	0.23
Other Current Liabilities	0.05	-	-	-	0.5	-
Total Current Liabilities	7.78	5.95	3.49	3.91	3.92	35.79
Long-Term Debt	-	-	-	0.48	0.47	0.59
Long-Term Leases	0.25	-	0.16	0.54	0.09	0.09
Total Liabilities	8.03	5.95	3.65	4.93	4.48	36.46
Common Stock	268.95	262.6	239.65	235.04	235.04	119.53
Additional Paid-In Capital	10.53	10.53	10.53	10.53	10.53	10.38
Retained Earnings	-297.99	-285.43	-266.33	-251.92	-232.54	-182.14
Comprehensive Income & Other	19.24	19.18	18.24	18	16.64	18.42
Total Common Equity	0.73	6.88	2.09	11.64	29.66	-33.81
Minority Interest	-	-	-	-	-	-0.01
Shareholders' Equity	0.73	6.88	2.09	11.64	29.66	-33.83
Total Liabilities & Equity	8.76	12.82	5.73	16.57	34.14	2.64
Total Debt	0.56	0.17	0.54	1.38	0.71	35.05
Net Cash (Debt)	5.01	9.6	2.44	11.75	29.66	-34.43
Net Cash Growth	478.20%	293.40%	-79.23%	-60.39%	-	-
Net Cash Per Share	0.01	0.03	0.01	0.06	0.37	-0.49
Filing Date Shares Outstanding	443.43	404	226.75	194.59	194.58	70.67
Total Common Shares Outstanding	443.43	404	226.75	194.59	194.58	70.67
Working Capital	-0.27	6.24	1.26	11.22	29.58	-34.04
Book Value Per Share	0.00	0.02	0.01	0.06	0.15	-0.48
Tangible Book Value	0.73	6.88	2.09	11.64	29.66	-33.99
Tangible Book Value Per Share	0.00	0.02	0.01	0.06	0.15	-0.48
Machinery	1.51	1.21	0.99	1.95	1.77	1.69
Leasehold Improvements	0.32	0.33	0.31	0.29	0.28	0.28

Source: S&P Global Market Intelligence. Standard template. Financial Sources.